These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1560432)

  • 1. Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides.
    Ellinboe JW; Alessi TR; Dolak TM; Nguyen TT; Tomer JD; Guzzo F; Bagli JF; McCaleb ML
    J Med Chem; 1992 Apr; 35(7):1176-83. PubMed ID: 1560432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel spirosuccinimides with incorporated isoindolone and benzisothiazole 1,1-dioxide moieties as aldose reductase inhibitors and antihyperglycemic agents.
    Wrobel J; Dietrich A; Woolson SA; Millen J; McCaleb M; Harrison MC; Hohman TC; Sredy J; Sullivan D
    J Med Chem; 1992 Nov; 35(24):4613-27. PubMed ID: 1469692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.
    Zask A; Jirkovsky I; Nowicki JW; McCaleb ML
    J Med Chem; 1990 May; 33(5):1418-23. PubMed ID: 2329563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperglycemic activity of novel naphthalenyl 3H-1,2,3,5-oxathiadiazole 2-oxides.
    Ellingboe JW; Lombardo LJ; Alessi TR; Nguyen TT; Guzzo F; Guinosso CJ; Bullington J; Browne EN; Bagli JF; Wrenn J
    J Med Chem; 1993 Aug; 36(17):2485-93. PubMed ID: 8355249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfluorocarbon-based antidiabetic agents.
    Kees KL; Smith TM; McCaleb ML; Prozialeck DH; Cheeseman RS; Christos TE; Patt WC; Steiner KE
    J Med Chem; 1992 Mar; 35(5):944-53. PubMed ID: 1548684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
    Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D
    J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T; Yoshioka S; Yoshioka T; Ushiyama I; Horikoshi H
    Diabetes; 1988 Nov; 37(11):1549-58. PubMed ID: 3053303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antidiabetic and hypolipidemic agents. 3. Benzofuran-containing thiazolidinediones.
    Reddy KA; Lohray BB; Bhushan V; Bajji AC; Reddy KV; Reddy PR; Krishna TH; Rao IN; Jajoo HK; Rao NV; Chakrabarti R; Dileepkumar T; Rajagopalan R
    J Med Chem; 1999 Jun; 42(11):1927-40. PubMed ID: 10354401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
    Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
    J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel thiazolidine-2,4-diones as potent euglycemic agents.
    Hulin B; Clark DA; Goldstein SW; McDermott RE; Dambek PJ; Kappeler WH; Lamphere CH; Lewis DM; Rizzi JP
    J Med Chem; 1992 May; 35(10):1853-64. PubMed ID: 1588563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
    Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
    Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihyperglycemic activity of new 1,2,4-oxadiazolidine-3,5-diones.
    Malamas MS; Sredy J; McCaleb M; Gunawan I; Mihan B; Sullivan D
    Eur J Med Chem; 2001 Jan; 36(1):31-42. PubMed ID: 11231047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design, synthesis, and hypoglycemic activity of a series of thiazolidine-2,4-diones.
    Oguchi M; Wada K; Honma H; Tanaka A; Kaneko T; Sakakibara S; Ohsumi J; Serizawa N; Fujiwara T; Horikoshi H; Fujita T
    J Med Chem; 2000 Aug; 43(16):3052-66. PubMed ID: 10956213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice.
    Kumar A; Sharma S; Gupta LP; Ahmad P; Srivastava SP; Rahuja N; Tamrakar AK; Srivastava AK
    Bioorg Med Chem; 2012 Mar; 20(6):2172-9. PubMed ID: 22341243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents.
    Avupati VR; Yejella RP; Akula A; Guntuku GS; Doddi BR; Vutla VR; Anagani SR; Adimulam LS; Vyricharla AK
    Bioorg Med Chem Lett; 2012 Oct; 22(20):6442-50. PubMed ID: 22981328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antihyperglycemic activity of 2-(substituted phenyl)-3-{[4-(1-naphthyl)-1,3-thiazol-2-yl] amino}-4-oxo-1,3-thiazolidin-5-ylacetic acid derivatives.
    Imran M; Yar MS; Khan SA
    Acta Pol Pharm; 2009; 66(1):51-6. PubMed ID: 19226969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents.
    Nomura M; Kinoshita S; Satoh H; Maeda T; Murakami K; Tsunoda M; Miyachi H; Awano K
    Bioorg Med Chem Lett; 1999 Feb; 9(4):533-8. PubMed ID: 10098657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.
    Cantello BC; Cawthorne MA; Cottam GP; Duff PT; Haigh D; Hindley RM; Lister CA; Smith SA; Thurlby PL
    J Med Chem; 1994 Nov; 37(23):3977-85. PubMed ID: 7966158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.